ArticleOncology letters2020

Celecoxib upregulates ULBP-1 expression in lung cancer cells via the JNK/PI3K signaling pathway and increases susceptibility to natural killer cell cytotoxicity.

Jayoung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.